Literature DB >> 2452092

Bipotential murine hemopoietic cell line (NFS-60) that is responsive to IL-3, GM-CSF, G-CSF, and erythropoietin.

K Hara1, T Suda, J Suda, M Eguchi, J N Ihle, S Nagata, Y Miura, M Saito.   

Abstract

NFS-60 cells were previously obtained from leukemia cells that were infected with the Cas-Br-M murine leukemia virus in vivo. We examined the proliferation and differentiation capacity of NFS-60 cells in the presence of native and recombinant (r) interleukin 3 (IL-3), recombinant granulocyte colony-stimulating factor (rG-CSF), recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF), and r-erythropoietin (Ep) using methylcellulose culture methods. This cell line was able to form colonies in response to each hemopoietic factor, but colony formation was rarely seen in their absence. Some populations of NFS-60 cells could differentiate into neutrophils and macrophages in the presence of IL-3 and GM-CSF. Moreover, in the presence of Ep, this cell line formed well-hemoglobinized colonies as well as nonerythroid colonies. In the presence of G-CSF, NFS-60 cells remained in the promyelocytic state. Electron microscopic studies confirmed these morphologies. A single-cell transfer experiment demonstrated that neutrophils, macrophages, and erythroblasts were derived from a single cell. It is concluded that the NFS-60 cell line is a factor-dependent, bipotential hemopoietic cell line.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452092

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  12 in total

1.  Cell-free production of scFv fusion proteins: an efficient approach for personalized lymphoma vaccines.

Authors:  Gregory Kanter; Junhao Yang; Alexei Voloshin; Shoshana Levy; James R Swartz; Ronald Levy
Journal:  Blood       Date:  2006-12-12       Impact factor: 22.113

2.  Sortase-catalyzed transformations that improve the properties of cytokines.

Authors:  Maximilian W Popp; Stephanie K Dougan; Tzu-Ying Chuang; Eric Spooner; Hidde L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-04       Impact factor: 11.205

3.  Erythropoietin changes the globin program of an interleukin 3-dependent multipotential cell line.

Authors:  T Enver; B Nakamoto; J Karlinsey; B Josephson; J Greenberger; T Papayannopoulou
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

4.  Different stromal cell lines support lineage-selective differentiation of the multipotential bone marrow stem cell clone LyD9.

Authors:  K H Lee; T Kinashi; K Tohyama; K Tashiro; N Funato; K Hama; T Honjo
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

5.  Enhanced non-viral gene delivery by coordinated endosomal release and inhibition of β-tubulin deactylase.

Authors:  Yoon Khei Ho; Li Han Zhou; Kam C Tam; Heng Phon Too
Journal:  Nucleic Acids Res       Date:  2017-04-07       Impact factor: 16.971

6.  Detection of granulocyte colony-stimulating factor produced by a newly established human hepatoma cell line using a simple bioassay system.

Authors:  K Tohyama; Y Yoshida; A Kubo; T Sudo; M Moriyama; H Sato; H Uchino
Journal:  Jpn J Cancer Res       Date:  1989-04

7.  Distinctive growth requirements and gene expression patterns distinguish progenitor B cells from pre-B cells.

Authors:  E A Faust; D C Saffran; D Toksoz; D A Williams; O N Witte
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

8.  Soluble prokaryotic overexpression and purification of bioactive human granulocyte colony-stimulating factor by maltose binding protein and protein disulfide isomerase.

Authors:  Bich Hang Do; Han-Bong Ryu; Phuong Hoang; Bon-Kyung Koo; Han Choe
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

9.  Induction of differentiation of mouse myeloid leukemia M1 cells by serum of patients with chronic myeloid leukemia.

Authors:  J Okabe-Kado; Y Honma; M Hayashi; M Hozumi; K Sampi; M Sakurai; K Hino; N Tsuruoka
Journal:  Jpn J Cancer Res       Date:  1988-12

10.  Production of multiple growth factors by a newly established human thyroid carcinoma cell line.

Authors:  K Tohyama; Y Yoshida; K Ohashi; E Sano; H Kobayashi; K Endo; M Naruto; T Nakamura
Journal:  Jpn J Cancer Res       Date:  1992-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.